Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
If you live with any of the following fitness-related health conditions, you too may be a candidate: Sarcopenia Sarcopenia is age-related muscle loss, a condition that comes for us all to some degree.23 After a certain point, you can expect to lose 3-8% of your muscle mass for every decade you live.24 Maximizing muscle growth now, or preserving the muscle you have, can keep you from losing too much lean tissue as you grow older
May enhance the appearance of thicker fuller hair and reduced shedding
BPC-157 and TB-500 are complementary regenerative peptides, BPC-157 dominates VEGFR2 angiogenesis and FAK-paxillin migration (tendon, GI healing), TB-500 dominates G-actin sequestration and stem-cell mobilisation (muscle and cardiac regeneration)
The Fat Loss Mechanism The proposed fat loss mechanism of 5-amino-1MQ operates through several interrelated effects: NNMT inhibition preserves SAM and NAD+ pools Increased NAD+ supports sirtuin activity and mitochondrial function Reduced lipogenesis adipocyte fatty acid synthesis is decreased Enhanced adipocyte metabolism improved adipose tissue function Selective effect on adipocytes relative sparing of other tissues Preclinical studies have shown that 5-amino-1MQ treatment in mice produces: Reduced body fat mass Improved insulin sensitivity Preserved lean mass Favorable effects on liver fat in diet-induced obesity models The Human Clinical Trials Picture As of 2026, human clinical trial activity for 5-amino-1MQ is emerging but not yet mature
This orexigenic effect sets it apart from other GHRPs and makes it particularly well-suited for study in models of cachexia and post-catabolic recovery
US$ 23.08
US$ 21.91
US$ 25.75
US$ 24.05
